The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
My confidence in this share is going up……but I’m scared of getting carried away. Been disappointed before. Feels like it might be well founded this time though.
Quite a few sells today relative to buys. I’m holding and wish I could buy more. If they can execute the strategy then this share is bound to do well.
COYR!!
A biggish jump this morning and no comments?
Came a cropper here under Parsons and still deep under water. Holding about 13k shares. Confidence growing that new team will deliver but am I confident enough to buy a few more to bring down my average? I’d be happy with 20p. Is there any chance it could reach that?
Life in the old dog yet.
Axe would love to think you’re right and have the courage to buy now but currently am in the once bitten category.
This is the third AIM share where I’ve lost relatively big, partly sucked in by the hype. Not more than I can afford to lose which is key.
I wouldn’t worry. Nothing is going to happen until next quarters results are published or there is something significant to report on one or more of the projects.
For me it’ll be by the end of the month. “Early 2022” means Jan or Feb. March would qualify under Q1 but not “early”.
Thanks Aandi. Very useful. Tempting.
I was alerted to this share this morning and the basic proposition sounds interesting so I’m thinking of investing. Loss making though and my guess is investors will be asked for more money before the company starts turning a profit. Am I wrong?
Since this study isn’t due to be completed until Monday I can’t see the RNS coming out until Tuesday or later at the latest. Happy to be proved wrong!
https://clinicaltrials.gov/ct2/show/study/NCT05207293?term=Synairgen&draw=2&rank=2
The company has just tweeted a reminder about what they are doing about Covid. RNS tomorrow?
You cannot be serious. I miss JP like I miss a hole in the head.
Yep. Same boat and hoping and waiting for some kind of payout but it won’t cover my losses. Terry should be prosecuted in my view but it won’t happen. Much more wary of AIM stocks as a result mind you so useful lesson learnt.
I reckon they are desperate to tell us but can’t just yet for some reason so used Twitter to maintain a positive stance. I’m taking it as a really good sign. If the news were bad would they have tweeted?
This treatment is going to become available just at the point when the older age group reach the end of their 10 week booster immunity waning. Great news for them and for us.
I think 50p is a stretch. My average is 32p. 10p would be a result in my view but I think 5p-7p is more realistic.
Does anyone know if it’s possible to invest in Aerogen? Assuming things take off - I’m very hopeful - then the delivery system will surely do as well as the treatment itself. Just can’t find it on either London or New York exchanges.